19 January 2021 - Deborah Wilkes
McKesson Europe has a new chief financial officer, Sweden’s Enzymatica has made changes to its management team, and the US Council for Responsible Nutrition (CRN) has a new chair.
McKesson Europe has a new finance chief
McKesson Europe has promoted Holger Landauer to chief financial officer.
The wholesaler and retailer said Landauer reported directly to Kevin Kettler, chairman of the Management Board and president of McKesson International.
Landauer was previously finance and IT director and a member of the country board of GEHE. McKesson Europe pointed out that he had led its German business into the joint venture with Walgreens Boots Alliance (WBA) that was finalised in November 2020 (click here to read the News story).
He joined McKesson Europe in 2005 and has spent his entire career with the company.
Landauer replaces Alain Vachon who announced his retirement in summer 2020.
Enzymatica makes changes to top team
Sweden’s Enzymatica has recruited two new executives and reorganised its existing management team.
Malin Richter has joined Enzymatica as director operations. She comes from Johnson & Johnson where she was head of plan at McNeil in Sweden. She has also worked for Pfizer and Pharmacia & Upjohn.
Kristoffer Ahlerup will be Enzymatica’s director commercial from 1 February 2021. Ahlerup is currently with L’Oréal as brand director for the La Roche-Posay and CeraVe dermocosmetic brands in the Nordic region. He has also worked for AAK, Ferrosan and Reckitt Benckiser (RB).
The Swedish company has also reorganised its existing management team to reflect its international expansion.
Johan Lindvall has moved from chief technical officer to director global project management.
Ulf Blom – director of sales and marketing, and one of the founders of Enzymatica – is taking on the new role of director innovation. He will focus on development of new products and new indications.
Ann-Christine Provoost, director of regulatory affairs, is taking on a broader scope of responsibilities, including pre-clinical and clinical development.
US CRN has a new chair
The US Council for Responsible Nutrition (CRN) has announced that Barry Ritz of Atrium Innovations is now chair of its Board of Directors.
The trade association for the dietary supplement and functional food industry made Ritz chair-elect in 2019.
Ritz is chief scientific officer and vice-president, professional, R&D and regulatory affairs for Atrium Innovations, the vitamins, minerals and supplements (VMS) specialist that is part of Nestlé Health Science. He will be chair of the CRN through 2022
He succeeds Bayer Consumer Health’s David Campbell